ALEXANDRA WILLIAMS: Open Payments
NPI 1710493267 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,159 in 116 payments from 20 companies in 2025. Trend: 2023 $1,735 · 2024 $2,420 · 2025 $2,159
Food & beverage: $2,159
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $268 |
| ABBVIE INC. | 13 | $230 |
| UCB, Inc. | 6 | $206 |
| Regeneron Healthcare Solutions, Inc. | 6 | $201 |
| E.R. Squibb & Sons, L.L.C. | 13 | $199 |
| Incyte Corporation | 6 | $180 |
| Janssen Biotech, Inc. | 8 | $177 |
| Arcutis Biotherapeutics, Inc. | 17 | $149 |
| GENZYME CORPORATION | 7 | $129 |
| LEO Pharma Inc. | 5 | $90 |
Products named: DUPIXENT, COSENTYX, Bimzelx, Sotyktu, OPZELURA, TREMFYA, RINVOQ, Zoryve.
Industry payments across OK — which companies pay providers there.
